The Role of Overweight and Obesity in Calcium Oxalate Stone Formation

Roswitha Siener, Sara Glatz, Claudia Nicolay, +1

Obesity Research

Omega-3 Fatty Acids and Low Carbohydrate Diet for Maintenance of Remission in Crohn's Disease: A Randomized Controlled Multicenter Trial

H. Lorenz‐Meyer, Peter Bauer, Claudia Nicolay, +7

Scandinavian Journal of Gastroenterology

Dietary risk factors for hyperoxaluria in calcium oxalate stone formers

Roswitha Siener, Dagmar Ebert, Claudia Nicolay, +1

Kidney International

NutritionUrologyDietary Risk FactorsPhysiologyClinical Nutrition +7

Exenatide compared with long‐acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long‐Acting insulin (HEELA) study

Melanie J. Davies, Richard Donnelly, Anthony Barnett, +3

Diabetes Obesity and Metabolism

THE EFFICACY OF DIETARY INTERVENTION ON URINARY RISK FACTORS FOR STONE FORMATION IN RECURRENT CALCIUM OXALATE STONE PATIENTS

Roswitha Siener, NATALIE SCHADE, Claudia Nicolay, +2

The Journal of Urology

Osteoporosis in haemophilia – an underestimated comorbidity?

T. Wallny, Daniela Scholz, Johannes Oldenburg, +5

Haemophilia

Bone DiseaseBone HealthBody CompositionOrthopaedic SurgeryHematology +10

MRI in the diagnosis of sporadic Creutzfeldt–Jakob disease: a study on inter-observer agreement

Henriette J. Tschampa, Kai Kallenberg, Horst Urbach, +4

Brain

Sporadic Creutzfeldt-jakob DiseaseCreutzfeldt-jakob DiseaseNeurological DisorderDiagnosis14-3-3 Proteins +16

Discovery of drug–omics associations in type 2 diabetes with generative deep-learning models

Rosa Lundbye Allesøe, Agnete Troen Lundgaard, Ricardo Hernández Medina, +164

Nature Biotechnology

Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials

Adem Y. Dawed, Andrea Mari, Andrew Brown, +173

The Lancet Diabetes & Endocrinology

Risk of severe hypoglycemia in sulfonylurea‐treated patients from diabetes centers in Germany/Austria: How big is the problem? Which patients are at risk?

Nanette C. Schloot, Axel Haupt, Morten Schütt, +6

Diabetes/Metabolism Research and Reviews